Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01063114 : Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma
PhasePhase 2
AgesMin: 3 Years Max: 25 Years
Inclusion Criteria:

- Participants must have undergone biopsy or attempted surgical resection and must have
histologically confirmed medulloblastoma or pineoblastoma.

- Participants may have had a gross total resection, sub-total resection or biopsy

- For patients with no prior chemotherapy, treatment must start within 35 days of
definitive surgery or as indicated if enrolled on therapeutic study

- Age range between 3 and 25 at the time of enrollment

- Life expectancy of greater than 3 months

- Blood laboratory values as outlined in the protocol

- Women of child-bearing potential and men must agree to use adequate contraception
prior to study entry and for the duration of study participation

Exclusion Criteria:

- Patients with more than one previous chemotherapy regimen

- Patients with recurrent or progressive disease after one or more regimens of
pre-radiation chemotherapy

- Patients with prior radiation therapy

- Any major uncontrolled or poorly controlled intercurrent illness that would limit
compliance with study requirements

- Pregnant women
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557